Max Herrmann

Herrmann, Max


Born May 14, 1865, in Berlin; died Nov. 17, 1942, in the Terezin concentration camp. German historian of literature and the theater. Founder of German scientific study of the theater.

Herrmann began teaching at the University of Berlin in 1891 with a course on the history of literature. From 1901 he concentrated on the history and theory of the theater. He was the author of Research on the History of the German Theater of the Middle Ages and the Renaissance, published in 1914. He used extensive documentary material and endeavored to recreate plays of the past. However, his idealistic worldview made him view the theatrical productions of the past as isolated from general historical and literary developments. In 1923 the Institute of Theater History was established at the University of Berlin on his initiative. After the fascist coup d’etat in Germany, he was removed from his post of professor and confined in a concentration camp where he died.


Albrecht von Byb und die Frühzeit des Deutschen Humanismus in Nürnberg. Berlin, 1893.
Die Reception des Humanismus in Nürnberg. Berlin, 1898.
Jahrmarktsfest zu Plundersweilern: Entsehungs- und Bühnengeschichte. Berlin, 1900.
Forschungen zur deutschen Theatergeschichte des Mittelalters und der Renaissance, vols. 1-2. Dresden, 1955.
Die Bühnenidee des Hans Sachs. Berlin, 1924.


Gvozdev, A. A. Iz istorii teatra i dramy. Petrograd, 1923.
References in periodicals archive ?
M2 EQUITYBITES-15 April 2010-Silence Therapeutics names Max Herrmann as CFO and company secretary(C)2010 M2 COMMUNICATIONS http://www.
They're (S&N) paying a low price, but they're taking on the risk of some of Centerpulse's liabilities,' said Max Herrmann, an industry analyst at ING Financial Markets.
Max Herrmann, analyst at ING Charterhouse, said the drug would help sales of the Avandia franchise reach pounds 1.
Corporate IT must manage the myriad of technical and administrative complexities associated with software delivery in an environment of constantly shrinking budgets and limited staff resources," said Max Herrmann, Vice President of Marketing and Strategy at New Moon Systems.
Max Herrmann, analyst at ING Charterhouse, believed it was unlikely that Bristol-Myers would be able to solve Glaxo's pipeline problems.
ING Charterhouse analyst Max Herrmann analyst said it was unlikely that Bristol-Myers would be able to solve Glaxo's pipeline problems.
Housebroker Max Herrmann at ING Barings said: 'Dechra is just a distributor and has no influence over vet's pricing policy.
We are very excited about entering into this strategic alliance with Ingram Micro," said Max Herrmann, president and CEO at LogiCad3D Inc.
Max Herrmann, pharmaceutical analyst at ING Charterhouse, said, "It's partly Crestor but given the speed the shares came off it's probably also profit taking.
Max Herrmann, of ING Charterhouse, said GSK was beginning to respond to City fears about its thinning pipeline of products.